**Correct Answer:** D. Malonyl-CoA

**Core Concept:** Carnitine Palmitoyl Transerase-1 (CPT-1) is a key enzyme involved in beta-oxidation of long-chain fatty acids in the mitochondria. The activity of CPT-1 is regulated by various factors, including malonyl-CoA.

**Why the Correct Answer is Right:** Malonyl-CoA is an endogenous inhibitor of CPT-1. Malonyl-CoA is synthesized from acetyl-CoA and malonyl-CoA via carboxylation. The increase in malonyl-CoA levels leads to the inhibition of CPT-1, which in turn slows down the entry of fatty acids into mitochondria for beta-oxidation.

**Why Each Wrong Option is Incorrect:**

A. Insulin: While insulin can stimulate fatty acid uptake and storage, it does not directly inhibit CPT-1.
B. Glucose: Glucose and insulin are not directly related to CPT-1 regulation.
C. Lactate: Lactate is not involved in regulating CPT-1 activity.
D. Malonyl-CoA: This is the correct answer, as mentioned above.

**Clinical Pearl / High-Yield Fact:** Understanding the regulation of CPT-1 is crucial for understanding the role of fatty acid oxidation in various physiological conditions, such as ketogenesis, fasting, and diabetes mellitus. Malonyl-CoA levels are influenced by insulin and glucagon levels, which can affect the organism's energy homeostasis. In fasting or starvation, insulin levels decrease, leading to increased malonyl-CoA levels and subsequently inhibiting CPT-1. This inhibits fatty acid oxidation and promotes ketogenesis, where the body produces ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone) as an alternative energy source. In diabetes mellitus, malonyl-CoA levels may be altered, affecting beta-oxidation and potentially contributing to hyperlipidemia and other complications.